Search details
1.
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study.
Clin Infect Dis
; 76(3): 497-505, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35731948
2.
Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments.
Antimicrob Agents Chemother
; 67(4): e0140122, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-36877034
3.
Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii.
Antimicrob Agents Chemother
; 95(5)2023 05 01.
Article
in English
| MEDLINE | ID: mdl-33558291
4.
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
J Antimicrob Chemother
; 78(4): 953-964, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36794692
5.
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
J Antimicrob Chemother
; 77(6): 1694-1705, 2022 05 29.
Article
in English
| MEDLINE | ID: mdl-35257162
6.
Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.
BMC Infect Dis
; 20(1): 556, 2020 Jul 31.
Article
in English
| MEDLINE | ID: mdl-32736602
7.
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
Am J Respir Crit Care Med
; 200(3): 370-380, 2019 08 01.
Article
in English
| MEDLINE | ID: mdl-30694692
8.
Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
J Infect Dis
; 219(6): 975-985, 2019 02 23.
Article
in English
| MEDLINE | ID: mdl-30597040
9.
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.
J Antimicrob Chemother
; 74(10): 2994-3002, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31273386
10.
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis.
Am J Respir Crit Care Med
; 198(9): 1208-1219, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-29877726
11.
Artificial intelligence-derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S284-S292, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496458
12.
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges.
Clin Infect Dis
; 67(suppl_3): S349-S358, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496464
13.
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs.
Clin Infect Dis
; 67(11): 1743-1749, 2018 11 13.
Article
in English
| MEDLINE | ID: mdl-29697766
14.
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S317-S326, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496457
15.
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S274-S283, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496459
16.
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S293-S302, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496461
17.
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.
Antimicrob Agents Chemother
; 62(2)2018 02.
Article
in English
| MEDLINE | ID: mdl-29180526
18.
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
Clin Infect Dis
; 64(10): 1350-1359, 2017 May 15.
Article
in English
| MEDLINE | ID: mdl-28205671
19.
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.
Antimicrob Agents Chemother
; 61(8)2017 08.
Article
in English
| MEDLINE | ID: mdl-28584143
20.
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
Antimicrob Agents Chemother
; 61(11)2017 11.
Article
in English
| MEDLINE | ID: mdl-28807911